Sinn P L, Davis D R, Sigmund C D
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
J Biol Chem. 1999 Dec 10;274(50):35785-93. doi: 10.1074/jbc.274.50.35785.
We generated transgenic mice with two P1 artificial chromosomes, each containing the human renin (HREN) gene and extending to -35 and -75 kilobase pairs, respectively. HREN protein production was restricted to juxtaglomerular cells of the kidney, and its expression was tightly regulated by angiotensin II and sodium. The magnitude of the up- and down-regulation in HREN mRNA caused by the stimuli tested was identical to the endogenous renin gene, suggesting tight physiological regulation. P1 artificial chromosome mice were mated with transgenic mice overexpressing human angiotensinogen to determine if there was a chronic compensatory down-regulation of the transgene. Despite a 3-fold down-regulation of HREN mRNA, plasma angiotensin II and blood pressure was modestly elevated in the double transgenic mice. Nevertheless, this elevation was significantly less than a different double transgenic model containing a poorly regulated HREN transgene. The increase in blood pressure, despite the decrease in HREN mRNA, suggests that the HREN gene can partially, but not completely, compensate for excess circulating angiotensinogen. These data suggest the possibility that increases in circulating or tissue angiotensinogen may cause an increase in blood pressure in humans, even in the presence of a functionally active servo-mechanism to down-regulate HREN expression.
我们培育了带有两条P1人工染色体的转基因小鼠,每条染色体分别包含人肾素(HREN)基因,并分别延伸至-35和-75千碱基对。HREN蛋白的产生仅限于肾脏的球旁细胞,其表达受到血管紧张素II和钠的严格调控。所测试的刺激引起的HREN mRNA上调和下调幅度与内源性肾素基因相同,表明存在严格的生理调节。将P1人工染色体小鼠与过表达人血管紧张素原的转基因小鼠交配,以确定转基因是否存在慢性代偿性下调。尽管HREN mRNA下调了3倍,但双转基因小鼠的血浆血管紧张素II和血压仍适度升高。然而,这种升高明显低于另一种含有调控不佳的HREN转基因的双转基因模型。尽管HREN mRNA减少,但血压升高表明HREN基因可以部分但不能完全补偿循环中血管紧张素原的过量。这些数据表明,即使存在功能活跃的伺服机制来下调HREN表达,循环或组织中血管紧张素原的增加仍可能导致人类血压升高。